MicroSectors FANG and Innovation 3X Leveraged ETN vs Philip Morris International Inc. — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $28.89, while Philip Morris International Inc. trades at $185.93 (market cap $281.91B). The key difference: Philip Morris International Inc. pays a 3.25% dividend while MicroSectors FANG and Innovation 3X Leveraged ETN pays none, and Philip Morris International Inc. is trading nearer its 52-week high, MicroSectors FANG and Innovation 3X Leveraged ETN nearer its low. Which is the better fit depends on your goals.
| FNGU | PM | |
|---|---|---|
Sector | Leveraged / Inverse | Consumer Staples |
52-Week High | $36.15 | $191.86 |
52-Week Low | $13.73 | $144.33 |
Market Cap | — | $281.91B |
Enterprise Value | — | $328.41B |
Dividend Yield | — | 3.25% |
Signals from Pluang's Aura AI — not financial advice
FNGU, a 3X leveraged ETN tracking the FANG+ Index, trades at $28.77, down 0.45% on the day. The technical picture is mixed, with moving averages signaling bullish momentum but oscillators and a high RSI indicating overbought conditions. Recent news highlights the extreme volatility and decay inherent to its leveraged structure, with one report noting a $10,000 position losing 16% in a single session in June 2026.
The outlook is dominated by the product's high-risk, tactical nature. The opportunity lies in capturing amplified gains during strong bullish trends in mega-cap tech. The primary risk is significant capital erosion during volatile or sideways markets due to daily resetting leverage and compounding costs, making it unsuitable for long-term holding.
No Aura AI signal available yet.
Trailing returns across standard periods
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →